Saltar al contenido
Merck

Hyperventilation in severe diabetic ketoacidosis.

Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies (2005-06-29)
Robert C Tasker, Daniel Lutman, Mark J Peters
RESUMEN

To explore whether the carbon dioxide-bicarbonate (P(CO(2))-HCO(3)) buffering system in blood and cerebrospinal fluid (CSF) in diabetic ketoacidosis should influence the approach to ventilation in patients at risk of cerebral edema. Medline search, manual search of references in articles found in Medline search, and use of historical literature from 1933 to 1967. A clinical vignette is used--a child with severe diabetic ketoacidosis who presented with profound hypocapnia and then deteriorated--as a basis for discussion of integrative metabolic and vascular physiology. Studies included reports in diabetic ketoacidosis where arterial and CSF acid-base data have been presented. Studies where simultaneous acid-base, ventilation, respiratory quotient, and cerebral blood flow data are available. We revisit a hypothesis and, by reassessing data, put forward an argument based on the significance of low [HCO(3)](CSF) and rising Pa(CO(2))- hyperventilation in diabetic ketoacidosis and the limit in biology of survival; repair of severe diabetic ketoacidosis and Pa(CO(2))-and mechanical ventilation. The review highlights a potential problem with mechanical ventilation in severe diabetic ketoacidosis and suggests that the P(CO(2))--HCO(3) hypothesis is consistent with data on cerebral edema in diabetic ketoacidosis. It also indicates that the recommendation to avoid induced hyperventilation early in the course of intensive care may be counter to the logic of adaptive physiology.

MATERIALES
Número de producto
Marca
Descripción del producto

Sigma-Aldrich
Acetona, ACS reagent, ≥99.5%
Sigma-Aldrich
Acetona, suitable for HPLC, ≥99.9%
Sigma-Aldrich
Glicerol, ACS reagent, ≥99.5%
Sigma-Aldrich
Glicerol, Molecular Biology, ≥99.0%
Sigma-Aldrich
Glicerol, ReagentPlus®, ≥99.0% (GC)
Sigma-Aldrich
Acetona, HPLC Plus, for HPLC, GC, and residue analysis, ≥99.9%
Sigma-Aldrich
1-Butanol, 99.9%
Sigma-Aldrich
1-Butanol, ACS reagent, ≥99.4%
Sigma-Aldrich
Glicerol, ≥99.5%
Sigma-Aldrich
1-Butanol, suitable for HPLC, ≥99.7%
Sigma-Aldrich
Glicerol solution, 83.5-89.5% (T)
Sigma-Aldrich
Glicerol, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for electrophoresis, ≥99% (GC)
Sigma-Aldrich
Glicerol, BioUltra, Molecular Biology, anhydrous, ≥99.5% (GC)
Supelco
Glicerol, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Acetona, ACS reagent, ≥99.5%
Sigma-Aldrich
Glicerol, BioXtra, ≥99% (GC)
Sigma-Aldrich
1-Butanol, puriss. p.a., ACS reagent, reag. ISO, reag. Ph. Eur., ≥99.5% (GC)
Supelco
Acetona, analytical standard
Sigma-Aldrich
1-Butanol, anhydrous, 99.8%
Sigma-Aldrich
Methylglyoxal solution, ~40% in H2O
Sigma-Aldrich
Dimethylamine solution, 40 wt. % in H2O
Sigma-Aldrich
Dimethylamine solution, 2.0 M in THF
Sigma-Aldrich
Glicerol, FCC, FG
Sigma-Aldrich
3-Hydroxybutyric acid, 95%
Sigma-Aldrich
Acetona, histological grade, ≥99.5%
Sigma-Aldrich
Glicerol, meets USP testing specifications
Sigma-Aldrich
Dodecanedioic acid, 99%
Sigma-Aldrich
1-Butanol, Molecular Biology, ≥99%
Supelco
Acetona, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
L-Carnitine inner salt, synthetic, ≥98%